BeOne Medicines Ltd.
Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –
BeOne Medicines GAAP Gross Margin (% of Global Product Sales) by Year
GAAP Gross Margin (% of Global Product Sales) (%)
BeOne Medicines GAAP Gross Margin (% of Global Product Sales): 87.3% in FY2025, up 3.0 pts from a year earlier.
Where the FY2025 figure comes from
“Gross Margin as a percentage of global product sales for the fourth quarter and full year of 2025 was 90.4% and 87.3%, compared to 85.6% and 84.3%”
Source: Form 8-K (filed 2026-02-26) ↗
Reported in Form 8-K EX-99.1 Earnings Releases & Form 10-Q / 10-K MD&A.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | GAAP Gross Margin (% of Global Product Sales) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 87.3% | +3.0 pts | Form 8-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 84.3% | +1.6 pts | Form 8-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 82.7% | +5.5 pts | Form 8-K (filed 2025-02-27) ↗ |
| FY2022 | Dec 31, 2022 | 77.2% | +3.2 pts | Form 8-K (filed 2024-02-26) ↗ |
| FY2021 | Dec 31, 2021 | 74.0% | – | Form 8-K (filed 2023-02-27) ↗ |
Breakdown
What makes up GAAP Gross Margin (% of Global Product Sales)
Cite this data
StockData. (2026). BeOne Medicines GAAP Gross Margin (% of Global Product Sales) (%), annual FY2021–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/gaap-gm-pct
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.